Long-term effect of dupilumab on prevention of lung function decline in patients with uncontrolled moderate-to-severe asthma: ATLAS trial design

Long-term effect of dupilumab on prevention of lung function decline in patients with uncontrolled moderate-to-severe asthma: ATLAS trial design

Background Many patients with asthma experience loss of lung function over time, and in certain patients this can lead to progressive obstructive patterns similar to COPD. Patients with severe asthma may experience accelerated lung function decline (LFD). However, characteristics and risk factors fo...

Full description

Bibliographic Details
Main Authors: Lucia De Prado Gomez, Ian Pavord, William Busse, Christopher E. Brightling, Michael E. Wechsler, Klaus F. Rabe, Mei Zhang, Jun Xing, Juby A. Jacob-Nara, Paul J. Rowe
Format: Article
Language:English
Published: European Respiratory Society 2023-03-01
Series:ERJ Open Research
Online Access:http://openres.ersjournals.com/content/9/2/00417-2022.full

Internet

http://openres.ersjournals.com/content/9/2/00417-2022.full

Similar Items